Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR2 | O95136 | 8/20 | 0.55 |
| ▸ | S1PR1 | P21453 | 8/20 | 0.55 |
| ▸ | S1PR3 | Q99500 | 8/20 | 0.55 |
| ▸ | S1PR4 | O95977 | 7/20 | 0.55 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.55 |
| ▸ | ANPEP | P15144 | 1/20 | 0.48 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.48 |
| ▸ | MMP2 | P08253 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.44 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.44 |
| ▸ | MMP1 | P03956 | 1/20 | 0.44 |
| ▸ | FDPS | P14324 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | ADH1B | P00325 | 1/20 | 0.41 |
| ▸ | ADH1C | P00326 | 1/20 | 0.41 |
| ▸ | ADH1A | P07327 | 1/20 | 0.41 |
| ▸ | ADH7 | P40394 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3435249 | 0.93 | S1PR2 (0.64) | S1PR2S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL10450207 | 0.91 | S1PR2 (0.68) | S1PR2S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL10450203 | 0.91 | S1PR2 (0.68) | S1PR2S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL5691575 | 0.91 | S1PR2 (0.68) | S1PR2S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL5689613 | 0.91 | S1PR2 (0.68) | S1PR2S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL5691935 | 0.91 | S1PR2 (0.68) | S1PR2S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL9745419 | 0.91 | S1PR2 (0.68) | S1PR2S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL10451801 | 0.91 | S1PR2 (0.68) | S1PR2S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL4422829 | 0.85 | — | — | |
| SCHEMBL5689630 | 0.84 | S1PR2 (0.59) | S1PR2S1PR1S1PR3S1PR4S1PR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108713044-B | Polycarbonate resin composition and molded article thereof | 出光兴产株式会社 | 2021-08-17 | — | — | CN | disclosed |
| US-10081554-B2 | Use of amino-containing neutral phosphine extractant in extraction and separation of thorium and process of using same | CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) | 2018-09-25 | — | — | US | disclosed |
| US-20170267540-A1 | USE OF AMINO-CONTAINING NEUTRAL PHOSPHINE EXTRACTANT IN EXTRACTION AND SEPARATION OF THORIUM AND PROCESS OF USING SAME | CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) | 2017-09-21 | — | — | US | disclosed |
| US-5099056-A | PROCESS FOR THE PRODUCTION OF N-SUBSTITUTED-AMINOMETHYLPHOSPHONIC ACID DIALKYLESTERS AND OF THE CORRESPONDING ACIDS | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 1992-03-24 | — | — | US | disclosed |
| EP-0385014-A1 | Process for preparation of substituted aminomethylphosphonic acids | CROMPTON & KNOWLES CORPORATION (US) | 1990-09-05 | — | — | EP | disclosed |
| EP-0385010-A1 | N-alkyl-N-(Aminophenylsulfonyl)-aminoalkylphosphonic acids and salts | CROMPTON & KNOWLES CORPORATION (US) | 1990-09-05 | — | — | EP | disclosed |
| US-4851158-A | N-alkyl-N-(aminophenylsulfonyl)-aminoalkylphosphonic acids | CROMPTON & KNOWLES CORPORATION (US) | 1989-07-25 | — | — | US | disclosed |
| US-4830788-A | Process for preparation of substituted-aminomethylphosphonic acids | CROMPTON & KNOWLES CORPORATION (US) | 1989-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10081554-B2 | Use of amino-containing neutral phosphine extractant in extraction and separation of thorium and process of using same | PHOSPHO1, PTMS, PRMT5 | S1PR2 1607/4885S1PR1 1537/4885S1PR3 1740/4885 |
| US-20170267540-A1 | USE OF AMINO-CONTAINING NEUTRAL PHOSPHINE EXTRACTANT IN EXTRACTION AND SEPARATION OF THORIUM AND PROCESS OF USING SAME | PHOSPHO1, PTMS, PRMT5 | S1PR2 1607/4885S1PR1 1537/4885S1PR3 1740/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.